Question 1

What is the catalog number for BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued?

Accepted Answer

The catalog number for BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued is B2709-01D1-ML750.

Question 2

What sizes are available for BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued?

Accepted Answer

BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued is available in the following size(s): 100 µL.

Question 3

Is BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued in stock?

Accepted Answer

BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (MaxLight 750) discontinued

Selected Variant

B2709-01D1-ML750

Size: 100 µL

Product Specifications

Clonality

Pab

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.